Utah Medical Products UTMD Stock
Utah Medical Products Price Chart
Utah Medical Products UTMD Financial and Trading Overview
Utah Medical Products stock price | 55.07 USD |
Previous Close | 95.31 USD |
Open | 95.7 USD |
Bid | 0 USD x 1000 |
Ask | 0 USD x 900 |
Day's Range | 95.08 - 97 USD |
52 Week Range | 80.1 - 109.5 USD |
Volume | 4.83K USD |
Avg. Volume | 5.76K USD |
Market Cap | 344.96M USD |
Beta (5Y Monthly) | 0.194366 |
PE Ratio (TTM) | 20.14407 |
EPS (TTM) | 3.96 USD |
Forward Dividend & Yield | 1.18 (1.23%) |
Ex-Dividend Date | June 15, 2023 |
1y Target Est | N/A |
UTMD Valuation Measures
Enterprise Value | 266.26M USD |
Trailing P/E | 20.14407 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.573362 |
Price/Book (mrq) | 2.9229305 |
Enterprise Value/Revenue | 5.074 |
Enterprise Value/EBITDA | 9.609 |
Trading Information
Utah Medical Products Stock Price History
Beta (5Y Monthly) | 0.194366 |
52-Week Change | 13.66% |
S&P500 52-Week Change | 20.43% |
52 Week High | 109.5 USD |
52 Week Low | 80.1 USD |
50-Day Moving Average | 94.63 USD |
200-Day Moving Average | 91.97 USD |
UTMD Share Statistics
Avg. Volume (3 month) | 5.76K USD |
Avg. Daily Volume (10-Days) | 8.84K USD |
Shares Outstanding | 3.63M |
Float | 3.19M |
Short Ratio | 6.94 |
% Held by Insiders | 6.46% |
% Held by Institutions | 72.53% |
Shares Short | 33.86K |
Short % of Float | 1.11% |
Short % of Shares Outstanding | 0.92% |
Dividends & Splits
Trailing Annual Dividend Rate | 1.17 |
Trailing Annual Dividend Yield | 1.22% |
5 Year Average Dividend Yield | 120.00% |
Payout Ratio | 0.24790001 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 32.68% |
Operating Margin (ttm) | 39.49% |
Gross Margin | 61.94% |
EBITDA Margin | 52.80% |
Management Effectiveness
Return on Assets (ttm) | 10.46% |
Return on Equity (ttm) | 15.10% |
Income Statement
Revenue (ttm) | 52.48M USD |
Revenue Per Share (ttm) | 14.46 USD |
Quarterly Revenue Growth (yoy) | 1.60% |
Gross Profit (ttm) | 32.2M USD |
EBITDA | 27.71M USD |
Net Income Avi to Common (ttm) | 17.15M USD |
Diluted EPS (ttm) | 4.72 |
Quarterly Earnings Growth (yoy) | 19.19% |
Balance Sheet
Total Cash (mrq) | 80.91M USD |
Total Cash Per Share (mrq) | 22.3 USD |
Total Debt (mrq) | 328K USD |
Total Debt/Equity (mrq) | 0.28 USD |
Current Ratio (mrq) | 15.659 |
Book Value Per Share (mrq) | 32.529 |
Cash Flow Statement
Operating Cash Flow (ttm) | 23.02M USD |
Levered Free Cash Flow (ttm) | 18.94M USD |
Profile of Utah Medical Products
Country | United States |
State | UT |
City | Midvale |
Address | 7043 South 300 West |
ZIP | 84047-1048 |
Phone | 801 566 1200 |
Website | https://www.utahmed.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 186 |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Q&A For Utah Medical Products Stock
What is a current UTMD stock price?
Utah Medical Products UTMD stock price today per share is 55.07 USD.
How to purchase Utah Medical Products stock?
You can buy UTMD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Utah Medical Products?
The stock symbol or ticker of Utah Medical Products is UTMD.
Which industry does the Utah Medical Products company belong to?
The Utah Medical Products industry is Medical Instruments & Supplies.
How many shares does Utah Medical Products have in circulation?
The max supply of Utah Medical Products shares is 3.28M.
What is Utah Medical Products Price to Earnings Ratio (PE Ratio)?
Utah Medical Products PE Ratio is 13.90656600 now.
What was Utah Medical Products earnings per share over the trailing 12 months (TTM)?
Utah Medical Products EPS is 3.96 USD over the trailing 12 months.
Which sector does the Utah Medical Products company belong to?
The Utah Medical Products sector is Healthcare.
Utah Medical Products UTMD included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 8098.63 USD — |
-5.98
|
— — | 8089.65 USD — | 8265.47 USD — | — - | — — |
NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}